Corvus Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US2210151005

SecurityCRVS / Corvus Pharmaceuticals, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership34,723 shares
Latest Disclosed Value $ 507,997
Simplex Trading, Llc ownership in CRVS / Corvus Pharmaceuticals, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 34,723 shares of Corvus Pharmaceuticals, Inc. (US:CRVS) valued at $507,997 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 5, 2025 disclosing 0 shares of Corvus Pharmaceuticals, Inc.. The current value of the position is $402,787 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (CRVS) in the form of stock options. The firm currently holds call options representing 69,000 of underlying shares valued at $1,009,470 USD and put options representing 113,300 of underlying shares valued at $1,657,579 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CRVS / Corvus Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 34,723 34,723 508 0.0003
2025-08-05 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -26,990 -100.00 0 0.0000
2025-05-12 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 26,990 -112,943 -80.71 0 0.0001
2025-02-11 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 139,933 134,263 2,367.95 1 0.0004
2024-11-08 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 5,670 3,458 156.33 0 0.0000
2024-07-25 2024-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 2,212 -7,134 -76.33 0 0.0000
2024-04-25 2024-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 9,346 -40,285 -81.17 0 0.0000
2024-02-02 2023-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 49,631 10,138 25.67 0 0.0001
2023-11-01 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 39,493 27,964 242.55 0 0.0000
2023-08-04 2023-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 11,529 11,529 0 0.0000
2023-04-27 2023-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 0 -21,419 -100.00 0 0.0000
2023-02-02 2022-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 21,419 5,369 33.45 0 -100.00 0.0000
2022-11-04 2022-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 16,050 -9,548 -37.30 13 -48.00 0.0000
2022-08-03 2022-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 25,598 5,524 27.52 25 -21.87 0.0000
2022-05-02 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 20,074 19,875 9,987.44 32 0.0000
2022-02-04 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 199 0 0.00 0 0.0000
2021-10-28 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 199 0 0.00 0 0.0000
2021-08-12 2021-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 199 -5,687 -96.62 0 -100.00
2021-04-26 2021-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 5,886 5,886 2,857.79 18 0.0000
2021-02-02 2020-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 0 -117 -100.00 0 -100.00 0.0000
2020-10-14 2020-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 117 117 0 0.0000
2020-07-13 2020-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -146 -100.00 0 0.0000
2020-04-29 2020-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 146 146 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F CORVUS PHARMACEUTICALS CALL Call 69,000 9.35 1,009 108.04 n/a n/a n/a
2026-02-11 2025-12-31 13F CORVUS PHARMACEUTICALS CALL Call 63,100 34.26 486 n/a n/a n/a
2025-11-12 2025-09-30 13F CORVUS PHARMACEUTICALS CALL Call 47,000 72.16 0 n/a n/a n/a
2025-08-05 2025-06-30 13F CORVUS PHARMACEUTICALS CALL Call 27,300 -30.71 0 n/a n/a n/a
2025-05-12 2025-03-31 13F CORVUS PHARMACEUTICALS CALL Call 39,400 -24.23 0 n/a n/a n/a
2025-02-11 2024-12-31 13F CORVUS PHARMACEUTICALS CALL Call 52,000 43.25 0 n/a n/a n/a
2024-11-08 2024-09-30 13F CORVUS PHARMACEUTICALS CALL Call 36,300 205.04 0 n/a n/a n/a
2024-07-25 2024-06-30 13F CORVUS PHARMACEUTICALS CALL Call 11,900 41.67 0 n/a n/a n/a
2024-04-25 2024-03-31 13F CORVUS PHARMACEUTICALS CALL Call 8,400 -57.14 0 n/a n/a n/a
2024-02-02 2023-12-31 13F CORVUS PHARMACEUTICALS CALL Call 19,600 78.18 0 n/a n/a n/a
2023-11-01 2023-09-30 13F CORVUS PHARMACEUTICALS CALL Call 11,000 -49.07 0 n/a n/a n/a
2023-08-04 2023-06-30 13F CORVUS PHARMACEUTICALS CALL Call 21,600 2,600.00 0 n/a n/a n/a
2023-04-27 2023-03-31 13F CORVUS PHARMACEUTICALS CALL Call 800 -92.73 0 n/a n/a n/a
2023-02-02 2022-12-31 13F CORVUS PHARMACEUTICALS CALL Call 11,000 6.80 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F CORVUS PHARMACEUTICALS CALL Call 10,300 1,616.67 8 n/a n/a n/a
2022-08-03 2022-06-30 13F CORVUS PHARMACEUTICALS CALL Call 600 -83.78 0 -100.00 n/a n/a n/a
2022-05-02 2022-03-31 13F CORVUS PHARMACEUTICALS CALL Call 3,700 -90.11 6 -93.33 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CORVUS PHARMACEUTICALS CALL Call 37,400 513.11 90 462.50 n/a n/a n/a
2022-02-04 2021-12-31 13F CORVUS PHARMACEUTICALS CALL Call 6,100 16 n/a n/a n/a
2021-10-28 2021-09-30 13F CORVUS PHARMACEUTICALS CALL Call 6,100 0.00 16 0.00 n/a n/a n/a
2021-08-12 2021-06-30 13F CORVUS PHARMACEUTICALS CALL Call 6,100 35,782.35 16 220.00 n/a n/a n/a
2021-04-26 2021-03-31 13F CORVUS PHARMACEUTICALS CALL Call 17 -95.60 5 -96.35 n/a n/a n/a
2021-02-02 2020-12-31 13F CORVUS PHARMACEUTICALS CALL Call 386 1,508.33 137 1,422.22 n/a n/a n/a
2020-10-14 2020-09-30 13F CORVUS PHARMACEUTICALS CALL Call 24 2,300.00 9 -93.43 n/a n/a n/a
2020-07-13 2020-06-30 13F CORVUS PHARMACEUTICALS CALL Call 1 -95.83 0 -100.00 n/a n/a n/a
2020-04-28 2020-03-31 13F CORVUS PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-05 2019-12-31 13F CORVUS PHARMACEUTICALS CALL Call 30 500.00 16 n/a n/a n/a
2019-10-15 2019-09-30 13F CORVUS PHARMACEUTICALS CALL Call 5 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F CORVUS PHARMACEUTICALS PUT Put 113,300 349.60 1,658 754.12 n/a n/a n/a
2026-02-11 2025-12-31 13F CORVUS PHARMACEUTICALS PUT Put 25,200 -16.56 194 n/a n/a n/a
2025-11-12 2025-09-30 13F CORVUS PHARMACEUTICALS PUT Put 30,200 151.67 0 n/a n/a n/a
2025-08-05 2025-06-30 13F CORVUS PHARMACEUTICALS PUT Put 12,000 -89.27 0 n/a n/a n/a
2025-05-12 2025-03-31 13F CORVUS PHARMACEUTICALS PUT Put 111,800 -75.88 0 -100.00 n/a n/a n/a
2025-02-11 2024-12-31 13F CORVUS PHARMACEUTICALS PUT Put 463,500 2,969.54 2 n/a n/a n/a
2024-11-08 2024-09-30 13F CORVUS PHARMACEUTICALS PUT Put 15,100 268.29 0 n/a n/a n/a
2024-07-25 2024-06-30 13F CORVUS PHARMACEUTICALS PUT Put 4,100 -43.06 0 n/a n/a n/a
2024-04-25 2024-03-31 13F CORVUS PHARMACEUTICALS PUT Put 7,200 -7.69 0 n/a n/a n/a
2024-02-02 2023-12-31 13F CORVUS PHARMACEUTICALS PUT Put 7,800 387.50 0 n/a n/a n/a
2023-11-01 2023-09-30 13F CORVUS PHARMACEUTICALS PUT Put 1,600 -67.35 0 n/a n/a n/a
2023-08-04 2023-06-30 13F CORVUS PHARMACEUTICALS PUT Put 4,900 345.45 0 n/a n/a n/a
2023-04-27 2023-03-31 13F CORVUS PHARMACEUTICALS PUT Put 1,100 -96.89 0 n/a n/a n/a
2023-02-02 2022-12-31 13F CORVUS PHARMACEUTICALS PUT Put 35,400 -4.07 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F CORVUS PHARMACEUTICALS PUT Put 36,900 188.28 30 150.00 n/a n/a n/a
2022-08-03 2022-06-30 13F CORVUS PHARMACEUTICALS PUT Put 12,800 -33.33 12 -61.29 n/a n/a n/a
2022-05-02 2022-03-31 13F CORVUS PHARMACEUTICALS PUT Put 19,200 186.57 31 93.75 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CORVUS PHARMACEUTICALS PUT Put 6,700 252.63 16 220.00 n/a n/a n/a
2022-02-04 2021-12-31 13F CORVUS PHARMACEUTICALS PUT Put 1,900 5 n/a n/a n/a
2021-10-28 2021-09-30 13F CORVUS PHARMACEUTICALS PUT Put 1,900 0.00 5 0.00 n/a n/a n/a
2021-08-12 2021-06-30 13F CORVUS PHARMACEUTICALS PUT Put 1,900 2,275.00 5 -79.17 n/a n/a n/a
2021-04-26 2021-03-31 13F CORVUS PHARMACEUTICALS PUT Put 80 433.33 24 380.00 n/a n/a n/a
2021-02-02 2020-12-31 13F CORVUS PHARMACEUTICALS PUT Put 15 -81.25 5 -79.17 n/a n/a n/a
2020-07-13 2020-06-30 13F CORVUS PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-29 2020-03-31 13F CORVUS PHARMACEUTICALS PUT Put 2 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.